Knight Therapeutics Inc
TSX:GUD
| US |
|
Matson Inc
NYSE:MATX
|
Marine
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
Airlines
|
| US |
|
Apple Inc
NASDAQ:AAPL
|
Technology
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.11
6.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
|
Matson Inc
NYSE:MATX
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
United Airlines Holdings Inc
NASDAQ:UAL
|
US |
|
|
Apple Inc
NASDAQ:AAPL
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
This alert will be permanently deleted.
Knight Therapeutics Inc
Cash Interest Paid
Knight Therapeutics Inc
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash Interest Paid
CA$9.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash Interest Paid
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash Interest Paid
$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash Interest Paid
$78.4m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Knight Therapeutics Inc
Glance View
Knight Therapeutics Inc engages in acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. The company is headquartered in Montreal, Quebec and currently employs 660 full-time employees. The company went IPO on 2014-02-28. The firm's principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. The Company’s products include BIJUVA Estradiol and Progesterone capsule, IMVEXXY Estradiol vaginal inserts, IBSRELA Tenapanor tablets, TRELSTAR Prostate Triptorelin, TRELSTAR Endometriosis Triptorelin, ILUVIEN Fluocinolone acetonide, Nerlynx Neratinib Tablets, Nerlynx Patient Checklist, Nerlynx Prescriber Checklist, Burinex Bumetanide, Probuphine Buprenorphine implant, Movantik Naloxegol and Neuragen. The company owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Its subsidiaries operates under United Medical, Biotoscana Farma and Laboratorio LKM.
See Also
What is Knight Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
9.3m
CAD
Based on the financial report for Sep 30, 2024, Knight Therapeutics Inc's Cash Interest Paid amounts to 9.3m CAD.
What is Knight Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 1Y
30%
Over the last year, the Cash Interest Paid growth was 30%.
You don't have any saved screeners yet
